Feature | April 08, 2014

CT Coronary Calcium Score Indicates Long-Term Heart Health

Five new studies at ACC.14 bolster evidence for coronary artery calcium scans as assessment tool

Philips CT, cardiac CTA, calcium scoring, ACC.14
April 7, 2014 — Coronary artery calcium scoring, a test that measures the amount and pattern of calcium that has accumulated in a patient’s coronary arteries, appears to provide an early indication of a person’s long-term risk for heart disease, according to data from five studies presented at the American College of Cardiology (ACC) 63rd Annual Scientific Session.
The test has been available for decades, but doctors and scientists debate whether and how it should be used to improve patient care. The new studies, some of which tracked patients for 10 years or more, show calcium scans to be better at predicting long-term heart problems than other available tests, particularly when evaluating low-risk patients.
“The studies suggest that we may have been underestimating the value of calcium scoring for detecting and managing patients with known or suspected coronary disease,” said Kim Allan Williams, Sr., M.D., FACC, vice president of the ACC and chief of cardiology at Rush University Medical Center in Chicago.
Coronary calcium indicates the extent to which plaque has accumulated and hardened in the heart’s main arteries and is an early sign of coronary heart disease, the number one cause of death for both men and women in the United States. Although the calcium itself is not dangerous, it contributes to the hardening of the arteries and its presence and pattern of accumulation reflects other conditions, such as narrowing of the arteries or an increased risk of dangerous blood clots, which can lead to heart attacks and impaired heart function.
Doctors measure coronary calcium using one of two types of computed tomography (CT) scanning machines: electron beam CT or multi-detector CT. The scans are non-invasive but expose patients to a low dose of radiation to give doctors a view of the heart.
Value as a First-Line Test for People with No Cardiac Symptoms
In a study of nearly 1,000 people tracked for an average of seven years, researchers at Houston Methodist Hospital in Texas found coronary calcium scores were significantly better at predicting cardiac events than two other heart disease tests, the Framingham 10-year risk calculator and the exercise treadmill test. The advantages of calcium scoring were especially prominent in the approximately 80 percent of participating patients considered to be at low risk for heart disease based on their treadmill test results. Lead study author Su Min Chang, M.D., said the results show that calcium scoring can help catch patients who are on the way to developing heart disease earlier than other available tests.
Twenty Years of Data Help Refine Assessments of Low-Risk Patients
A 20-year study of nearly 5,600 people offers new insights about the relative mortality risk of patients with no, low, moderate and high calcium scores who are otherwise considered to be at low risk for heart disease. Over an average follow-up period of 10 years, researchers at Los Angeles BioMed at Harbour UCLA Medical Center found that even patients with low calcium scores (1-99) were 50 percent more likely to die than patients with a calcium score of zero. Moderate scores (100-399) were associated with an 80 percent greater likelihood of dying and high scores (above 400) were associated with a three times greater risk of dying as compared to patients with zero calcium. Lead study authors Rine Nakanishi, M.D., Ph.D., and Matthew J. Budoff, M.D., FACC, said the results bolster the case for calcium scoring as a method to refine assessments of a person’s risk for heart disease and identify those who are most likely to benefit from treatment. 
A Powerful Indicator of the Risk of Heart Attack 
A study conducted at Israel’s Lady Davis Carmel Medical Center found coronary calcium scoring to be superior to other CT-based measures of a person’s heart health. Researchers tracked the long-term (eight-year) likelihood of death or heart attack among 620 patients who were referred for CT scanning after experiencing chest pain but who had not been previously diagnosed with coronary artery disease. Comparing three measurements taken during the scans: coronary calcium score, atheroma and luminal stenosis, the researchers found coronary calcium score to be the only independent CT predictor of death or heart attacks long-term after adjusting for clinical risk. Ronen Rubinshtein, M.D., lead study author, said the results suggest coronary calcium is a useful predictor of long-term health outcomes in patients with chest pain because it likely reflects the risk of both plaque accumulation and disease duration and activity, unlike other metrics tested in the study.
A Reflection of Overall Heart Health
Calcification in the coronary arteries is a common manifestation of unhealthy vascular aging and serves as a good predictor of poor cardiovascular outcomes. In contrast, a finding of a coronary artery calcium score of zero in a middle age or older adult is a sign of healthy aging and a good predictor of longevity. In a study of 1,850 participants from the Multi-Ethnic Study of Atherosclerosis (MESA), researchers at the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease showed that no single risk factor predicted which individuals would maintain a coronary artery calcium score of zero over a 10-year period. Analyzing demographic and lifestyle risk factors of study participants who had a calcium score of zero at the start of the study, they found that younger participants and those without multiple traditional cardiovascular risk factors were more likely to maintain a score of zero during a second scan taken 10 years later. Lead author Seamus Whelton, M.D., said the study shows that healthy arterial aging appears to be influenced predominantly by the long-term maintenance of a healthy lifestyle rather than any one specific risk factor. 
A Long-Term Complement to Detecting Heart Disease
A meta-analysis of 17 studies conducted by a research team from Mount Sinai St. Luke’s-Roosevelt Hospital Center in New York found a rough, though not perfect, correlation between coronary calcium scores and the results of a common test used to detect coronary heart disease known as SPECT-MPI, which uses single-photon CT scanning to provide a 3-D image of the heart. The analysis revealed that calcium scores of zero generally are associated with negative SPECT-MPI tests for coronary heart disease, while calcium scores above 400 are generally associated with abnormal SPECT-MPI results. The frequency of ischemia rose with an increasing calcium score. Because the tests reflect different aspects of heart health, the two can be complementary, with coronary calcium scans offering valuable insights about long-term heart disease risk and SPECT-MPI offering a clearer picture of the short-term risk of an adverse cardiac event, said lead study author Chirag Bavishi, M.D., MPH. 
For more information: CardioSource.org

Related Content

Philips, Lumify smart-device ultrasound, S4-1 cardiac transducer, RSNA 2016
Technology | Cardiovascular Ultrasound| October 14, 2016
Philips announced at The American College of Emergency Physicians' (ACEP) annual meeting that it has received 510(k)...
Toshiba CT, picking a CT scanner, choosing a CT scanner, CT 101, what to look for in CT scanners, Aquilion ONE ViSION

The Toshiba Aquilion One Vision system is among the new generation of CT systems on the market that offers several dose lowering technologies and a hardware/software combination to enhance image quality over previous-generation scanners.

Feature | CT Angiography (CTA)| October 14, 2016 | Dave Fornell
As hospitals begin replacing their first-generation 64-slice computed tomography (CT) scanners after a decade of use,
Robert M. Califf, FDA commissioner, future of cardiovascular medicine, JACC column
News | Business| September 23, 2016
Technology advances coupled with increased use of social media and personal devices could offer new possibilities for...
GE Healthcare, Mission Health, innovation collaboration, outcomes-based agreement, imaging, business
News | Business| August 30, 2016
August 30, 2016 — Mission Health and GE Healthcare announced a novel, 10-year...
Siemens Healthineers, Somatom Drive CT system, FDA clearance
Technology | Computed Tomography (CT)| August 30, 2016
Siemens Healthineers announced that the U.S. Food and Drug Administration (FDA) has cleared the Somatom Drive computed...
atomic bombs, radiation exposure, long-term health effects, Bertrand Jordan, study
News | Radiation Dose Management| August 19, 2016
The detonation of atomic bombs over the Japanese cities of Hiroshima and Nagasaki in August 1945 resulted in horrific...
Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

Feature | August 05, 2016 | Dave Fornell
CT angiography, CTA, coronary CT, cardiac CT, SCCT, society of cardiovascular computed tomography, cardiac imaging
Feature | CT Angiography (CTA)| August 03, 2016 | Dave Fornell
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting offers an in-depth review of all aspects of c
CT angiography, CTA, Medicare population, Harvey L. Neiman Health Policy Institute study, Neiman HPI
News | CT Angiography (CTA)| August 02, 2016
According to a new study, the last 13 years have seen substantial growth in the ordering of computed tomography...
CMS, Overall Hospital Quality Star Rating, national distribution, quailty of care
News | Business| July 26, 2016
July 25, 2016 — The Centers for Medicare and Medicaid Services (CMS) announced that it expects to launch its new Over
Overlay Init